|
|||||||||||||||
|
INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016 Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI) |
||||||||||||||
Issue: May 2024
Volume 9 | Issue 5
Review Result and Publication of Paper within : 2-3 days
Click Here For more DetailsFor Authors
Forms / Download
Published Issue Details
Editorial Board
Other IMP Links
Facts & Figure
Impact Factor : 8.76
Issue per Year : 12
Volume Published : 9
Issue Published : 96
Article Submitted :
Article Published :
Total Authors :
Total Reviewer :
Total Countries :
Indexing Partner
Join RMS/Earn 300
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
|
Published Paper Details
|
|
| Paper Title: | A Review on Ayurvedic,and Pharmacological Properties of Kuberaksh (Caesalpinia bonducella Fleming:.) |
| Authors Name: | Dr. Satish Pakanikar , Dr.Sreyash Shinde |
| Download E-Certificate: | Download |
| Author Reg. ID: |
IJNRD_205153
|
| Published Paper Id: | IJNRD2309236 |
| Published In: | Volume 8 Issue 9, September-2023 |
| DOI: | |
| Abstract: | ABSTRACT: Background: Kuberaksha (Caesalpinia bonducella Fleming:.) a member of Caesalpiniaceae family which is also known as Latakaranj. In Brihatrayi (Charak,Sushrut and Vagbhatta) there is no direct reference about the drug Kuberaksa. But Putikaranja, Prakirya, Putik and can be equated with Kuberaksha. Vagbhatta mentions "Karanj dravya" in Prameha chikitsa as one of the ingredients of "Dhanvantari Ghrita". But he does not use the term Kuberaksha. In the Nighantus, Karanja is indicated in Prameha. In Siddha system of medicine leaves of this plant are used in Diabetes Mellitus. In some tribal areas of Sabarkantha of North Gujarat, it is used in Madhumeha. In today's research era, there is lot of work being done on 'Caesalpinia bonducella' about its hypoglycemic activity. Ayurveda this plant is having Guna-Laghu,Ruksha , Ras Katu, Veerya-Ushna, Vipaka-Katu, Vaatahar and Kaphahar and Sheet . Many pharmacological studies have been conducted to investigate the properties of Kuberaksha (Caesalpinia bonducella Fleming:.) in an attempt to authenticate its use as a multi-purpose medicinal agent. The main aim of this article is to collect and analyze the scientific information related to traditional uses, bioactive chemical constituents and pharmacological activities. Methods: Scientific information on Kuberaksha (Caesalpinia bonducella Fleming:.) was retrieved from the online bibliographic databases (e.g. MEDLINE/PubMed, SciFinder, Web of Science, Google Scholar and Scopus) and books from central library as well as library of Dravyaguna department of Sai Ayurved College, Hospital and Research Centre Sasure-Vairag-Solapur. Results: According to Ayurveda Kuberaksha (Caesalpinia bonducella Fleming:.) it is effective in diabetes pharmacologically it act as analgesic,anti-inflametory,anti-oxidant,anti-cataract,anti-cancer,spermatogenic, it is very effective in pyrexia. Bonducine Alkaloids like Bonducine, Steroidal Saponin, Fatty Acids, Hydrocarbons, Phytosterols, Isoflavones, Amino acids and Phenolics, Phytosterols- Sitosterol, Heptocosane Noncrystalline Bitter Glycoside Bonducin Neutral Saponin were reported from whole plant or different plant parts. Conclusion: The mechanisms of action for these properties are not fully understood. Preliminary studies have found various constituents of Kuberaksha (Caesalpinia bonducella Fleming:.) exhibiting a variety of therapeutic effects. These results are very encouraging and indicate this herb should be studied more extensively to confirm these results and reveal other potential therapeutic effects. |
| Keywords: | Keywords: Kuberaksha, Latakaranj, Caesalpinia bonducella Fleming:. Ayurvedic uses; alkaloids; pharmacological activity |
| Cite Article: | "A Review on Ayurvedic,and Pharmacological Properties of Kuberaksh (Caesalpinia bonducella Fleming:.)", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.8, Issue 9, page no.c312-c315, September-2023, Available :http://www.ijnrd.org/papers/IJNRD2309236.pdf |
| Downloads: | 000118755 |
| ISSN: |
2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016 An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator |
| Publication Details: |
Published Paper ID:IJNRD2309236 Registration ID: 205153 Published In: Volume 8 Issue 9, September-2023 DOI (Digital Object Identifier): Page No: c312-c315 Country: Osmanabad, Maharashtra, India Research Area: Health Science Publisher : IJ Publication Published Paper URL : https://www.ijnrd.org/viewpaperforall?paper=IJNRD2309236 Published Paper PDF: https://www.ijnrd.org/papers/IJNRD2309236 |
| Share Article: |
|
|
Click Here to Download This Article |
|
| Article Preview | |
|
|
|
Major Indexing from www.ijnrd.org
| Semantic Scholar | Microsaoft Academic | ORCID | Zenodo |
| Google Scholar | ResearcherID Thomson Reuters | Mendeley : reference manager | Academia.edu |
| arXiv.org : cornell university library | Research Gate | CiteSeerX | PUBLON |
| DRJI | SSRN | Scribd | DocStoc |
ISSN Details
 |
 |
|
ISSN: 2456-4184
Impact Factor: 8.76 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016
DOI (A digital object identifier)
Conference
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Important Details
Social Media
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Join RMS/Earn 300
| Copyright © 2024 - All Rights Reserved - IJNRD |
Facebook Twitter Instagram LinkedIn